Quality on Sale: A Stable 2026 Guide and a Data-Center Growth Leg Meet an 18x Multiple

Results vs. Consensus

Year-over-Year (Q4)

Full-Year 2025

Revenue

Q4 consolidated revenue of $6.6B grew 9% reported and 4% underlying, with Consulting (+5%) again outpacing RIS (+2%). The RIS deceleration to 2% was the quarter's optical sore spot, but management was specific that it reflected difficult year-ago comparisons (elevated Torrance flood claims and the timing of Latin American 18-month policies) rather than a new deterioration. For the full year, both segments grew 4-5% underlying (RIS +4%, Consulting +5%), and total revenue crossed $27B. The organic algorithm settled at 4% for 2025, exactly the mid-single-digit framework management set a year ago, and the 2026 guide of "similar to 2025" keeps it there.

Margins

Q4 adjusted operating margin expanded 40bps to 23.7%, with RIS up 60bps to 27.6% and Consulting up 10bps to 20.8%. The full-year margin rose 30bps, the 18th consecutive year of expansion. The RIS margin recovery is the most important margin data point: after Q3's flat-RIS-margin scare, the segment re-levered, helped by Thrive efficiencies beginning to land and favorable mix. This is the proof point that management can manufacture margin expansion through a soft-growth stretch, which is precisely the bridge that keeps EPS compounding while organic sits at 4%.

EPS & Cash Flow

Q4 adjusted EPS of $2.12 grew 10%; full-year $9.75 grew 9%. The standout is cash: full-year free cash flow of $5.0B, up 25%, comfortably outgrowing earnings and funding a record $2B buyback ($1B in Q4 alone, opportunistically at the lows) plus ~$850M of acquisitions and a 10%-higher dividend. GAAP EPS of $1.68 carried $210M of Q4 noteworthy items, including $112M of Thrive charges. The cash-generation strength is the under-appreciated element of the quarter and a core reason the upgrade is warranted: a business throwing off $5B of FCF, growing it 25%, and returning it aggressively at a de-rated multiple is compounding intrinsic value per share quickly.

Segment Performance

Marsh Risk (insurance brokerage)

Marsh Risk grew 10% reported and 3% underlying (U.S./Canada +3%, international +4%, with EMEA +6%, Asia-Pacific +2%, Latin America -4% on the 18-month-policy comp). The 3% underlying is the same as Q3 and was further pressured by the year-ago Torrance flood claims comp. For the full year, Marsh Risk grew 4% underlying on 15% reported (McGriff). Management leaned hard on the digital-infrastructure opportunity and MMA's middle-market momentum as the 2026 growth engines.

"It's a 155-year-old business, maybe more relevant than it's ever been. We had 15% GAAP growth in Marsh Risk last year and 4% underlying growth." — John Doyle, President & CEO

Assessment: The 2-3% quarterly prints are the soft spot, but the comps are identifiable and the full-year 4% holds. With data-center construction, MMA, and casualty all building, Marsh Risk's 2026 organic should be stable-to-better, not worse. The market is now positioned for the bear case, which is what makes stability a positive surprise.

Guy Carpenter (reinsurance & capital)

Guy Carpenter grew 5% underlying again, the most consistent organic performer in the group, despite a January-1 reinsurance renewal that saw double-digit property-cat rate reductions. The offsets are powerful: record new business in 2025, a red-hot cat-bond market (86 bonds, $24B+ of limit), and a casualty market where rising primary rates (+19% U.S. excess casualty) flow into quota-share and new casualty sidecars. Management flagged ~$10B of new data-center reinsurance premium as the single biggest 2026 opportunity.

"There's been estimates of up to $10 billion of new premium entering the market in 2026... we think this is the single biggest new business opportunity in 2026." — Dean Klisura, CEO of Guy Carpenter

Assessment: The clearest example of the franchise growing through a soft pricing cycle by selling capital solutions, not rate. The data-center reinsurance and casualty-sidecar dynamics are real, sizeable, and underappreciated. Guy Carpenter is a structural-growth story masquerading as a rate-cycle victim.

Mercer (health, wealth, career)

Mercer grew 9% reported and 4% underlying: Health +6%, Wealth +5% (its best of the year, led by investments; AUM $692B, +12% YoY), and Career -2% (still soft on U.S. project work but improving from -5% in Q2). Full-year Mercer grew 4% underlying. Wealth re-accelerating to 5% and Career bottoming are quiet positives.

Assessment: Steady and gently improving. The Career drag is narrowing and Wealth is firming. Mercer is no longer a source of negative surprises, and the digital-infrastructure talent/mobility work (semiconductor mobility redesigns, skills programs) is a new demand thread.

Marsh Management Consulting (formerly Oliver Wyman Group)

The renamed consulting arm grew 8% underlying and posted its first billion-dollar quarter, with management noting 75% growth over five years. Demand is strong (three of the best-ever sales months in the trailing five), and management directly rebutted the bear narrative that AI will cannibalize consulting revenue, arguing AI raises productivity while clients still pay for outcomes.

"We're not really being paid for the things that AI can do at this stage. We're paid for helping clients deliver outcomes... not one at the moment which is experiencing revenue headwinds because of this." — Nick Studer, CEO of Marsh Management Consulting

Assessment: A standout. The first billion-dollar quarter, record sales months, and a credible, detailed AI-is-tailwind-not-threat argument make this the highest-momentum business in the portfolio. It also de-risks the "AI eats consulting" bear thesis that had been an overhang on the multiple.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: The most confident posture of our coverage window, and notably forward-leaning. Management spent the bulk of the call on offense, detailing a multi-segment digital-infrastructure opportunity and a maturing AI/Thrive strategy, rather than defending the 2% RIS print. The tone shift from Q3's strategy-heavy-but-growth-cautious stance to Q4's growth-confident stance was clear, and it was backed by a stable 2026 guide and record cash returns rather than rhetoric alone.

1. Full-Year 2025: The Framework Delivered

Marsh delivered exactly what it guided a year ago through a soft cycle: $27B revenue, 4% underlying, 18th straight year of margin expansion, $9.75 adjusted EPS (+9%), and $5B FCF (+25%). It completed the McGriff integration (its largest deal ever), launched the new brand, and stood up Thrive, all while returning a record $2B via buyback.

"For the full year, we generated 10% revenue growth, 4% underlying revenue growth, double-digit adjusted operating income growth, 9% adjusted EPS growth, and our 18th consecutive year of reported margin expansion." — John Doyle, President & CEO

Assessment: A textbook "deliver the framework in a hard year" result. The credibility this builds matters for how investors should weight the 2026 guide: management under-promised and delivered in 2025, which raises confidence that a "similar to 2025" 2026 is a floor, not a ceiling.

2. The 2026 Guide: Stable, Not Worse

Management guided 2026 underlying growth to "similar to 2025" (~4%), with continued margin expansion (a 19th year) and solid adjusted EPS growth, plus ~$5B of capital deployment. After three quarters in which the dominant fear was further deceleration, a stable guide was the catalyst.

"We currently expect underlying revenue growth will be similar to the level we generated in 2025. We also anticipate another year of margin expansion and solid adjusted EPS growth." — Mark McGivney, CFO

Assessment: The single most important sentence of the quarter. "Stable, not worse" resolves the open question that kept us at Hold. Combined with margin expansion and a raised $5B deployment, it sets a high-single-digit EPS-growth algorithm at a de-rated multiple, which is the core of the upgrade.

3. Digital Infrastructure / Data Centers: The New Growth Leg

Management devoted the longest stretch of the call to the data-center/digital-infrastructure opportunity, with all four business leaders detailing their angles: ~$3 trillion of investment over five years; 2,000-3,000 data centers to be built; Marsh holding leading share of a $205B 2025 data-center construction market; ~$10B of new reinsurance premium in 2026; plus Mercer talent/mobility work and consulting transformation work.

"Over the next five years, it's estimated that between 2,000 to 3,000 data centers will be constructed worldwide... in '25 alone, Marsh US had the leading market share of the $205 billion in data center construction package." — Martin South, CEO of Marsh Risk

Assessment: This is the optionality the bears have not priced. A multi-year, multi-segment secular build-out where Marsh already leads share is a credible source of upside to the 4% organic base. It will not show up as a step-change in any single quarter, but it materially de-risks the "structural 4% forever" bear thesis and gives the franchise a genuine growth narrative again.

4. RIS Organic at 2%: Comps, Not Collapse

RIS organic decelerated to 2% in Q4 (Marsh Risk +3%), which management attributed to specific tough comps: prior-year Torrance flood claims activity and Latin American 18-month policy timing. Full-year RIS organic held at 4%.

Assessment: The optics are poor but the explanation is credible and the full-year figure is intact. We treat the 2% as a comp artifact, not a new trend; the 2026 "similar to 2025" guide implies RIS organic stabilizes around 4% for the year. This is the one number bears will cite, and we think it is the weakest part of their case.

5. Brand Launch, Ticker Change, and Segment Renaming

Marsh officially launched its new masterbrand (ringing the NYSE closing bell) and changed its ticker to MRSH two weeks before the print. The consulting segment was renamed from Oliver Wyman Group to Marsh Management Consulting, and the broking unit is now "Marsh Risk." Legacy brands transition into the Marsh masterbrand over 2026.

Assessment: Administrative and largely cosmetic to the financials, now behind the company. With the transition complete, the change-uncertainty overhang that colored the Q3 reaction is gone.

6. Thrive: Executing on Schedule

Thrive is progressing: BCS is operational, dozens of AI productivity tools are deployed, and $112M of charges ran through Q4. Management reiterated ~$400M of savings against ~$500M of charges over three years, with a portion reinvested in talent, AI, and new growth areas (digital infrastructure, healthcare, private capital, energy).

"Thrive is a growth program. It'll certainly fuel efficiency and help us with margin expansion, but it's also going to enable us to accelerate investment." — John Doyle, President & CEO

Assessment: The RIS margin re-expansion (+60bps) is the first tangible Thrive proof point. Reframing Thrive as a growth-and-investment engine (not just cost-out) is the right narrative and is now backed by margin evidence. This underpins the 19th-margin-year guide.

7. Pricing: Soft P&C, Building Casualty

The Marsh rate index fell 4% (property -9%, casualty +4%, U.S. excess casualty +19%), and January-1 reinsurance saw double-digit cat reductions but rising casualty rates. Management's structural argument, that the rising cost of risk (casualty/litigation, climate, healthcare) eventually outpaces falling price, gained more force with casualty rate increases accelerating.

"Eventually, those costs will have to catch up with inflation. We're advising our clients to buy more coverage, particularly in casualty." — John Doyle, President & CEO

Assessment: The property-cat softness is a known 2026 headwind, but the casualty super-cycle (excess casualty +19%, sidecars, third-party capital) is an underappreciated offset that flows straight into Guy Carpenter's quota-share book. The pricing story is more two-sided than the bearish "rates are falling" headline.

8. Capital Allocation: Record Returns, $5B Plan

Marsh returned a record $2B via buyback in 2025 ($1B in Q4, opportunistic) and guided ~$5B of 2026 deployment, reiterating a philosophy that favors accretive M&A over buyback but commits to annual dividend increases and share-count reduction. The Q4 buyback ramp was a function of a thin M&A quarter (20 small deals, ~$850M).

"Our bias is to deploy a lot of capital to high-quality accretive acquisitions and our pipeline is very active." — Mark McGivney, CFO

Assessment: Exemplary. Buying back a record amount of stock at the de-rated lows is value-accretive, and the $5B 2026 plan (up from $4.5B) plus a strong M&A pipeline gives multiple levers for double-digit EPS growth even at 4% organic.

9. AI as Tailwind, Not Threat (Consulting)

Management directly addressed the bear worry that AI cannibalizes consulting, arguing AI lifts productivity while clients pay for outcomes, and that AI-transformation work (the "quotient" platform, the new DNA data-analytics business) is the fastest-growing part of the consulting arm.

Assessment: A credible, detailed rebuttal of a real overhang. Coupled with the first billion-dollar quarter and record sales months, it shifts AI from a perceived threat to a demonstrated demand driver, which should support the multiple.

10. Talent and Competitive Raids

Management again addressed competitor "team lifts," characterizing some PE-backed practices as unethical/illegal while sizing the impact as immaterial (retention above historic norms; 95,000+ colleagues; net additions to market-facing talent).

Assessment: A persistent irritant, not a thesis risk. Retention above norms and net talent additions confirm the franchise is winning the talent war on balance; the vocal pushback is brand defense, not a sign of damage.

Guidance & Outlook

The guide is deliberately conservative and, importantly, stable. The only explicit caution for modelers is Q1: the prior-year Q1 carried a discrete share-based-comp tax benefit that will not repeat, plus fiduciary income steps down to ~$83M, so Q1 2026 EPS growth will optically lag the full-year algorithm. Beyond that, the picture is mid-single-digit organic, a 19th margin-expansion year, ~$5B of deployment, and high-single-digit EPS growth.

Implied algorithm: ~4% organic + ~2-3 points of M&A + continued margin expansion + buyback, less rate/fiduciary drag, supports ~6-9% adjusted EPS growth to roughly $10.30-10.50. Data-center and casualty offer upside to the organic base.

Street at: Consensus 2026 adjusted EPS sits near $10.37 (+6.4%); the stable guide validates that and removes the downside-revision risk that pressured the stock through 2025.

Guidance style: Conservative and credible. Given management under-promised and delivered in 2025, we treat "similar to 2025" as a prudent floor with identified sources of upside.

Analyst Q&A Highlights

Reconciling Falling Reinsurance Rates With Organic Growth

An analyst asked how to square dramatic reinsurance rate decreases with Guy Carpenter's organic growth. Management acknowledged property-cat pricing as a 2026 headwind but pointed to record new business, casualty growth (sidecars, third-party capital), and data-center reinsurance as offsets.

Q: "We're seeing some pretty strong rate reductions... that looks kinda scary from the potential of organic revenue growth... I'm hoping you can just reconcile the moving parts as we process these pretty dramatic rate decreases in reinsurance."
— Greg Peters, Raymond James

A: "Property cat pricing rate environment will certainly be a headwind as we move through 2026... that said, we had record new business in 2025... we think the casualty market now is a clear growth opportunity for brokers and reinsurers."
— Dean Klisura, CEO of Guy Carpenter

Assessment: A convincing answer. Guy Carpenter has demonstrably grown 5% through a multi-year soft market by selling capital solutions and new structures. The data-center and casualty-sidecar dynamics are net-new growth sources that did not exist a year ago, which supports the "stable organic" thesis.

Will Consulting Lead and RIS Lag in 2026?

An analyst asked whether to expect Consulting to lead organic and RIS to run lower in 2026 given the P&C backdrop, or whether data centers offer brokerage upside. Management declined to guide by segment but expressed broad optimism, citing data infrastructure, healthcare, energy, private capital, and MMA strength.

Q: "Should we expect consulting to lead the pack on organic while maybe risk runs a bit lower given the backdrop in P&C? Or do your enthusiasm about data centers offer upside to brokerage as '26 progresses?"
— Mike Zaremski, BMO Capital Markets

A: "I wasn't trying to guide to strength in one area. We see good opportunity across all of our businesses... MMA is strong and front-footed... Thrive again is that capacity engine for us to drive earnings growth."
— John Doyle, President & CEO

Assessment: Management framed 2026 as broad-based rather than carried by one segment, which is more reassuring than a narrow bet. The refusal to guide by segment is standard; the breadth of cited opportunities (data infra, healthcare, energy, private capital) is the takeaway.

Squaring Data-Center Leadership With 3% Marsh Risk Growth

An analyst pressed on why Marsh's leading share of a $205B data-center construction market did not show up more visibly in the 3% Marsh Risk growth, and whether 2026 would be different. Management said data-center work was already a factor in 2025 and that far more of the build-out lies ahead.

Q: "I think I heard $205 billion in data center construction values that Marsh US handled the leading market share in 2025... it didn't look like that had a meaningful impact on the results with the 3% underlying growth... I'm just trying to square some of the comments that you made just with the stable underlying revenue growth outlook."
— David Motemaden, Evercore ISI

A: "Some of the investment that happened last year happened, and we're 4% or better underlying growth in all of our businesses last year. So it was a factor... but there's much more in front of us than is behind us in that build-out."
— John Doyle, President & CEO

Assessment: The fair pushback of the call. Data centers are not yet a needle-mover at the consolidated level, and management was honest that it is an ahead-of-us story. We read it as embedded optionality not yet in numbers or estimates, which is exactly the kind of upside that justifies paying up at a de-rated multiple.

Is Marsh Risk Organic Stabilizing?

An analyst noted Marsh Risk organic had slowed from 5% in Q1 to 3% in Q4 and asked whether management was implying stability rather than further deceleration. Management cautioned against over-indexing on any single quarter and pointed to the 4% full-year result and 2026 optimism.

Q: "You've seen a slowdown in growth over the last three, four quarters from 5% in 1Q to 3% in the fourth quarter... it seems like you are not expecting an incremental slowdown from here... is that correct or not?"
— Jimmy Bhullar, JPMorgan

A: "We cautioned you in the past not to over-index on any single quarter. We had 15% GAAP growth at Marsh Risk for the year [and] 4% underlying growth... we're optimistic about our prospects next year."
— John Doyle, President & CEO

Assessment: Management effectively confirmed stabilization, not further deceleration, in the flagship business. That is the answer that matters most for the thesis: the 2026 guide implies RIS organic holds near 4%, and the Q4 2% was a comp artifact.

AI as a Headwind to Consulting?

An analyst raised the bear concern that AI could cannibalize project work at the former Oliver Wyman. Management rebutted it in detail, distinguishing commoditizable tasks (which AI does) from outcome delivery (what clients pay for), and framing AI-transformation work as the fastest-growing part of consulting.

Q: "For the management consulting business, formerly Oliver Wyman, there could be some project-related stuff that actually goes the way of AI and maybe a headwind... What are the potential maybe revenue losses that you could see?"
— Brian Meredith, UBS

A: "We're not really being paid for the things that AI can do at this stage. We're paid for helping clients deliver outcomes... I expect to hire the same or more junior staff members because they are quite AI literate... not one at the moment which is experiencing revenue headwinds because of this."
— Nick Studer, CEO of Marsh Management Consulting

Assessment: The most thesis-relevant Q&A exchange. A detailed, credible rebuttal of the "AI eats consulting" overhang, backed by a first billion-dollar quarter and record sales. It removes a structural worry that had been suppressing the multiple.

When Do Lower Public Multiples Reset Private M&A Prices?

An analyst asked how long it takes for the de-rating in public broker valuations to filter into private M&A multiples. Management said the bid-ask gap has grown as public comps fell, with high-quality assets still holding out for premium prices and some deals trading at disappointing outcomes.

Q: "We've seen a significant deterioration over the last couple of years in the valuation of publicly traded insurance brokers from an M&A front. How long does it take before that filters into M&A multiples?"
— Meyer Shields, KBW

A: "The bid-ask gap has probably grown. We've seen some pretty meaningful assets come off the market... High quality assets, though, are still kind of insisting on higher multiples."
— John Doyle, President & CEO

Assessment: Disciplined and patient. A widening bid-ask means Marsh will not overpay, and a reset in private multiples over time would make its ~$5B-a-year deployment more accretive. A constructive medium-term dynamic for the M&A flywheel.

What They're NOT Saying

1. No segment-level 2026 guidance. Management would not say whether Consulting leads or RIS lags, leaving the organic mix for investors to infer. Standard, but it keeps the data-center upside un-quantified.
2. Data-center revenue is not sized. Despite extensive narrative, management gave no dollar revenue figure for its own data-center book, only market-size and share statistics, so the 2026 contribution remains qualitative.
3. No explicit 2026 EPS range. "Solid growth" is the only EPS guide; management did not bracket it, leaving the Street's ~$10.37 as the reference and the Q1 tax/fiduciary headwinds as the only quantified texture.
4. Thrive savings cadence still vague. Beyond ~$400M over three years and the $112M of Q4 charges, there is no explicit 2026 savings figure, so the margin-expansion bridge is directional rather than precise.
5. McGriff organic still undisclosed. With McGriff now in the underlying base in 2026, management again declined to quantify its standalone organic, leaving the quality of U.S. middle-market growth partly opaque.

Market Reaction

• Pre-print setup: Stock closed $178.18 entering the print, down 4.0% YTD, down 18.8% over the trailing twelve months, and within ~1% of its 52-week closing low ($176.58), against an S&P up only 1.9% YTD. A deeply de-rated, washed-out setup.
• Reaction-day session (Jan 29): Gapped up ~+2.4% to open $182.50, then rallied through the session to close $187.92, up 5.5% (+$9.74) on ~3.6M shares (~1.4x the 30-day average).
• S&P 500 reaction day: -0.1%, so Marsh outperformed the tape by nearly 6 points.

The asymmetry tells the story. A stock down ~19% over twelve months, sitting near its lows at ~18x, needed only "stable, not worse" to rally hard, and that is what the 2026 guide delivered. Layer on the record FCF and buyback, the RIS margin recovery, and the data-center optionality, and the print cleared a very low bar by a wide margin. The +5.5% on moderate (not euphoric) volume suggests the move was relief and short-covering more than a wholesale re-rating, which means there is room for the multiple to continue recovering if 2026 plays out as guided. For us, the reaction confirms the thesis pivot: with the deceleration priced in, good-enough news is enough to move the stock up.

Street Perspective

Debate: Is "Stable, Not Worse" Enough to Re-Rate?

Bull view: Yes. A fortress compounder that has de-rated from ~22x to ~18x on cyclical (not structural) deceleration re-rates as soon as the deceleration fear is removed; a stable 2026 guide plus record cash return is the trigger, and the multiple has ample room to recover toward its historical low-20s.

Bear view: No. "Similar to 2025" is still ~4% organic with property pricing falling all year; an 18x multiple is only modestly cheap for a mid-single-digit grower, and without organic re-acceleration the stock just grinds with EPS rather than re-rating.

Our take: We side with the bulls, with eyes open. The de-rating overshot the modest fundamental slowdown, and at ~18x you are paid to wait via a ~2% dividend, a record buyback shrinking the share count, and free call options on data centers and the casualty super-cycle. Even absent multiple expansion, high-single-digit EPS growth at a de-rated entry beats the market; with modest multiple recovery, it beats it comfortably.

Debate: Real Growth Re-Acceleration or Cost-Engineered EPS?

Bull view: Data centers ($3T build-out, leading share), casualty sidecars, healthcare, and private capital are genuine new organic legs that lift the base above 4% over 2026-2027, while Thrive funds the investment; this is real growth returning, not just cost-out.

Bear view: The EPS algorithm still rests on margin, buyback, and M&A, not organic; data-center revenue is unquantified and far off, and 2026 organic is explicitly guided flat to 2025, so the "growth is back" narrative is aspirational.

Our take: The truth is in between, and that is fine for an Outperform. Even if 2026 organic stays at 4%, the levers deliver high-single-digit EPS growth at a cheap multiple. The data-center and casualty stories are upside optionality we are not paying for, not the base case we are underwriting.

Debate: Quality Compounder at a Cyclical Low

Bull view: You rarely buy a wide-moat, 18-year margin-grower with $5B of FCF at ~18x. The setup (washed-out sentiment, near 52-week lows, stable guide, record buyback at the lows, secular optionality) is a classic quality-on-sale entry; accumulate.

Bear view: Cyclically-exposed brokers can stay cheap through a soft pricing cycle; with rates and P&C pricing still falling into 2026, the cycle low for the multiple may not be in, and "cheap" can get cheaper.

Our take: We accept the cycle risk but think the risk/reward is clearly favorable at ~18x with the deceleration priced and a stable guide in hand. This is the entry our initiation explicitly said we were waiting for. We are taking it.

Model Update Needed

Valuation framework: At $187.92, on ~$10.40 of 2026E adjusted EPS, the stock trades at ~18.1x forward, down from ~22x at our initiation six months ago and near the low end of its multi-year range. For a wide-moat compounder growing EPS high-single-digit with a 19th margin-expansion year, $5B of deployment, and unpriced data-center/casualty optionality, a fair multiple is ~20-22x, implying fair value of roughly $208-229, about 11-22% above the reaction-day close, plus a ~1.9% dividend. The risk/reward that was balanced-to-negative at initiation is now clearly positive.

Thesis Scorecard Post-Earnings

Grading the standing thesis (established Q2 2025, maintained Q3 2025).

Overall: Thesis strengthened materially. Both bear pillars have de-fanged: the valuation bear point is resolved (the de-rating happened), and the deceleration bear point is stabilizing and priced in. The bull pillars are all confirmed and gaining a new growth narrative (digital infrastructure). The conditions our initiation set for an upgrade, an organic stabilization or a multiple reset toward the high-teens, have both been met.

Action: Upgrade to Outperform from Hold. Buy the quality on sale: ~18x for a fortress compounder with a stable 2026, record cash return, and unpriced secular optionality. Risks to monitor: property-cat pricing falling faster than expected, a sharper U.S. economic slowdown hitting the cyclical 15-20% of revenue, and the optical Q1 EPS-growth dip.